IPSC technology: Platform for drug discovery

Clinical Pharmacology and Therapeutics

Volumn 89, Issue 5, 2011, Pages 639-641

  Ellis, J ^a,b,c,d   Bhatia, M ^e,f  

^a SickKids   (Canada)

^b Ontario Consortium of Regenerating Inducing Therapeutics (OCRiT)   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

^e MCMASTER UNIVERSITY   (Canada)

^f MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

ARTICLE; CELL DIFFERENTIATION; DISEASE SEVERITY; DRUG METABOLISM; DRUG RESEARCH; EMBRYONIC STEM CELL; HUMAN; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; SOMATIC CELL;

ANIMALS; CELL DIFFERENTIATION; DRUG DISCOVERY; DRUG EVALUATION, PRECLINICAL; HUMANS; INDUCED PLURIPOTENT STEM CELLS;

EID: 79955456661     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2011.22     Document Type: Article

References (10)

1. Yamanaka, S. A fresh look at iPS cells. Cell 137, 13-17 (2009).
2. Warren, L. et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 7, 618-630 (2010).
3. Ebert, A.D. et al. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 457, 277-280 (2009).
4. Lee, G. et al. Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. Nature 461, 402-406 (2009).
5. Moretti, A. et al. Patient-specific induced pluripotent stem-cell models for long-QT syndrome. N. Engl. J. Med. 363, 1397-1409 (2010).
6. Chan, E.M. et al. Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells. Nat. Biotechnol. 27, 1033-1037 (2009).
7. Kim, K. et al. Epigenetic memory in induced pluripotent stem cells. Nature 467, 285-290 (2010).
8. Miura, K. et al. Variation in the safety of induced pluripotent stem cell lines. Nat. Biotechnol. 27, 743-745 (2009).
9. Ebert, A.D. & Svendsen, C.N. Human stem cells and drug screening: opportunities and challenges. Nat. Rev. Drug Discov. 9, 367-372 (2010).
10. Szabo, E. et al. Direct conversion of human fibroblasts to multilineage blood progenitors. Nature 468, 521-526 (2010).